Pachyvitelliform Maculopathy Case Series and Review, 2020–2025

Supplementary material for a study characterizing pachyvitelliform maculopathy (PVM), a novel retinal phenotype. The retrospective analysis includes patient records from 2020–2025 at two ophthalmic centers, evaluating therapeutic responses to half-dose photodynamic therapy and subthreshold micropulse laser. The document was authored by figshare admin karger and last updated in June 2026.

Use Cases

• Reviewing clinical presentation and multimodal imaging features of PVM based on the case series description.
• Analyzing therapeutic outcomes for PVM based on the described interventions of hd-PDT and SML.
• Comparing PVM progression and diagnostic criteria with other macular dystrophies based on the study's conclusions.

Strengths

• Includes a specific temporal coverage of patient records from 2020 to 2025.
• Focuses on a novel and diagnostically challenging retinal phenotype (PVM) with defined diagnostic criteria.
• Evaluates two specific therapeutic modalities (half-dose PDT and subthreshold micropulse laser).

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• The dataset is very small (58.6 KB), indicating limited scope, likely a supplementary document.

Provenance

Source

figshare admin karger

Collection Method

Retrospective study analyzing patient records from two ophthalmic centers.

Time Range

2020–2025

Freshness

Last updated 2026-06-03 05:55:28; freshness should be verified.

Geography

null